State Cannabis Legalization and Psychosis-Related Health Care Utilization
This article originally appeared at https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800728 Authors: Holly Elser, MD, PhD1,2; Keith Humphreys, PhD3,4; Mathew V. Kiang, ScD5; et alSwapnil Mehta, MD4; Jong H. Yoon, MD4,6; William O. Faustman, PhD4,6; Ellicott C. Matthay, PhD7 JAMA Netw Open. 2023;6(1):e2252689. doi:10.1001/jamanetworkopen.2022.52689 Key Points Question Is state cannabis legalization or commercialization associated with increased rates of psychosis-related health care claims? Findings In this cohort study of claims data from 63 680 589 beneficiaries from…